Technical Articles
Chronic kidney disease
Erythropoietin: A Pleiotropic Cytokine Beyond Anemia Treatment
Erythropoietin is a sialic acid glycoprotein with a molecular weight of approximately 30-34 kDa, traditionally defined as a classic hematopoietic growth factor specifically produced by the kidneys, which acts in a hormonal manner on the bone marrow to dominate erythropoiesis.
View details
- Stem Cells
- EPO protein
- Erythropoietin
- Erythropoiesis
- Anemia treatment
- Chronic kidney disease
- Recombinant EPO
- Hypoxia-inducible factor
- JAK-STAT pathway.
α - Klotho: Key regulatory factors decoding anemia in chronic kidney disease
In recent years, studies have found that abnormal expression of the anti-aging gene α - Klotho (KL) is closely associated with CKD anemia. Its high expression in the kidneys makes it a key molecule connecting kidney function and hematopoietic regulation. Although multiple clinical studies have confirmed a significant decrease in alpha Klotho levels in CKD patients with anemia, the regulatory network behind this molecular change still needs to be further elucidated.
View details
- Immunity/Inflamma
- α - Klotho
- Chronic kidney disease
- anemia
ASGR1: Exploration and Challenges of a New Target for Lipid-lowering Therapy
Asialoglycoprotein receptor 1 (ASGR1 for short), which shows great application prospects in the regulation of cholesterol metabolism and the treatment of cardiovascular diseases.
View details
- Cardiovascular
- Klotho/FGF23 axis
- chronic kidney disease
- mineral metabolism disorder
- 1














